BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 28513810)

  • 1. Epstein-Barr virus encephalitis in solid organ transplantation.
    Lau JSY; Low ZM; Abbott I; Shochet L; Kanellis J; Kitching AR; Korman TM
    New Microbiol; 2017 Jul; 40(3):212-217. PubMed ID: 28513810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].
    Merlino C; Giacchino F; Bergallo M; Bonello F; Bollero C; Segoloni GP; Cavallo R
    G Ital Nefrol; 2003; 20(2):170-5. PubMed ID: 12746803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein Barr viral load monitoring by quantitative PCR in renal transplant patients.
    Merlino C; Cavallo R; Bergallo M; Giacchino F; Bollero C; Negro Ponzi A; Cavallo G
    New Microbiol; 2003 Apr; 26(2):141-9. PubMed ID: 12737195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein--Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate.
    Mentzer SJ; Perrine SP; Faller DV
    Transpl Infect Dis; 2001 Sep; 3(3):177-85. PubMed ID: 11493400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus encephalitis presenting with a tumor-like lesion in an immunosuppressed transplant recipient.
    Khalil M; Enzinger C; Wallner-Blazek M; Scarpatetti M; Barth A; Horn S; Reiter G
    J Neurovirol; 2008 Nov; 14(6):574-8. PubMed ID: 18991070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus encephalitis in a renal allograft recipient diagnosed by polymerase chain reaction on cerebrospinal fluid and successfully treated with ganciclovir.
    MacGinley R; Bartley PB; Sloots T; Johnson DW
    Nephrol Dial Transplant; 2001 Jan; 16(1):197-8. PubMed ID: 11209035
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and virologic outcomes in high-risk adult Epstein-Barr virus mismatched organ transplant recipients.
    Kumar D; Patil N; Husain S; Chaparro C; Bhat M; Kim SJ; Humar A
    Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28489256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysphagia and right leg weakness in a renal transplant patient.
    Munang ML; Mutagi A; Bailey MS; Osman H
    J Clin Virol; 2013 Oct; 58(2):363-6. PubMed ID: 23582985
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
    Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Allen UD; Preiksaitis JK;
    Clin Transplant; 2019 Sep; 33(9):e13652. PubMed ID: 31230381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encephalitis caused by Epstein-Barr virus in a renal transplant recipient.
    Garamendi I; Montejo M; Cancelo L; Lopez L; Aguirrebengoa K; Martín A; Zarraga S
    Clin Infect Dis; 2002 Jan; 34(2):287-8. PubMed ID: 11740719
    [No Abstract]   [Full Text] [Related]  

  • 12. A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder.
    Humar A; Hébert D; Davies HD; Humar A; Stephens D; O'Doherty B; Allen U
    Transplantation; 2006 Mar; 81(6):856-61. PubMed ID: 16570008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral prophylaxis and the Epstein Barr virus-related post-transplant lymphoproliferative disorder.
    Davis CL; Harrison KL; McVicar JP; Forg PJ; Bronner MP; Marsh CL
    Clin Transplant; 1995 Feb; 9(1):53-9. PubMed ID: 7742583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation.
    Höcker B; Böhm S; Fickenscher H; Küsters U; Schnitzler P; Pohl M; John U; Kemper MJ; Fehrenbach H; Wigger M; Holder M; Schröder M; Feneberg R; Köpf-Shakib S; Tönshoff B
    Transpl Int; 2012 Jul; 25(7):723-31. PubMed ID: 22533698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Remission of severe disease induced by CMV and lymphoproliferative post-transplant disease after changing the immunosuppressive regime].
    Gómez E; Melón S; Fresno MF; Tricas L; Navascués R; de Oña M; Herreros M; Alvarez Grande J
    Nefrologia; 2002; 22(6):574-81. PubMed ID: 12516292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
    Fellner MD; Durand KA; Solernou V; Bosaleh A; Balbarrey Z; García de Dávila MT; Rodríguez M; Irazu L; Alonio LV; Picconi MA
    Rev Argent Microbiol; 2016; 48(2):110-8. PubMed ID: 27157146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
    Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
    Transpl Infect Dis; 2009 Oct; 11(5):393-9. PubMed ID: 19497070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valganciclovir suppressed Epstein Barr virus reactivation during immunosuppression with alemtuzumab.
    Gill H; Hwang YY; Chan TS; Pang AW; Leung AY; Tse E; Kwong YL
    J Clin Virol; 2014 Apr; 59(4):255-8. PubMed ID: 24507802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No effect of treatment with intravenous ganciclovir on Epstein-Barr virus viremia demonstrated after pediatric liver transplantation.
    Østensen AB; Sanengen T; Holter E; Line PD; Almaas R
    Pediatr Transplant; 2017 Sep; 21(6):. PubMed ID: 28653462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.